Streetbeat News

Price Targets

XOMA

HC Wainwright & Co. analyst Joseph Pantginis maintains a Buy rating on XOMA Royalty (NASDAQ:XOMA) and raises the price target from $74 to $117.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 10:22 am

ARMP

HC Wainwright & Co. has reiterated its Buy rating on Armata Pharmaceuticals (AMEX:ARMP) and maintained a $7 price target, as stated by analyst Joseph Pantginis.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 10:18 am

XERS

HC Wainwright & Co. has reiterated its Buy rating on Xeris Biopharma Holdings (NASDAQ:XERS) and maintained a price target of $6.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 10:14 am

SLE

HC Wainwright & Co. analyst Scott Buck has reiterated a Buy rating on Super League Enterprise (NASDAQ:SLE) and maintained a $3 price target.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 10:09 am

NKTX

HC Wainwright & Co. analyst Emily Bodnar maintains a Buy rating on Nkarta (NASDAQ:NKTX) but lowers the price target from $23 to $22.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 10:05 am

PGR

Goldman Sachs has upgraded Progressive (NYSE:PGR) from Neutral to Buy and raised the price target from $230 to $262.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 10:03 am

OCUP

HC Wainwright & Co. analyst Matthew Caufield maintains a Buy rating on Ocuphire Pharma (NASDAQ:OCUP) but lowers the price target from $20 to $18.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 10:03 am

MLYS

HC Wainwright & Co. analyst Matthew Caufield has reiterated a Buy rating on Mineralys Therapeutics (NASDAQ:MLYS) and maintained a $30 price target.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 10:01 am

PNC

B of A Securities has upgraded PNC Financial Services Group (NYSE:PNC) from Neutral to Buy and raised the price target from $185 to $200.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 9:59 am

VYNE

HC Wainwright & Co. has reiterated its Buy rating on VYNE Therapeutics and maintained a price target of $5.75.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 9:57 am